Dublin, June 02, 2026 (GLOBE NEWSWIRE) -- The "U.S. Contraceptive Market Size, Share & Trends Analysis Report by Product, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.
The U.S. contraceptive market is poised for significant growth, with a current valuation of USD 8.4 billion in 2025 expected to surge to USD 12.4 billion by 2033, reflecting a CAGR of 4.9% from 2026 to 2033. This anticipated market expansion is largely driven by the increased adoption of modern contraceptive methods and heightened awareness among adolescents and young adults regarding sexual health and family planning.
Government initiatives play a pivotal role in enhancing access to contraceptives, effectively reducing unwanted pregnancies among teenagers. Recent developments in the sector, including product innovations, regulatory approvals, and public health initiatives, are broadening contraceptive options and improving accessibility, thereby propelling market growth in the U.S.
U.S. Contraceptive Market Report Segmentation
The comprehensive report offers revenue forecasts at the national level, alongside an analysis of prevailing industry trends within various sub-segments from 2021 to 2033. The report meticulously segments the U.S. contraceptive market by product type and region.
Product Outlook (Revenue, USD Billion, 2021-2033)
- Pills
- Intrauterine Devices (IUD)
- Hormonal IUD
- Nonhormonal IUD
- Condoms
- Male Condoms
- Female Condoms
- Vaginal Ring
- Subdermal Implants
- Injectable
- Others
Region Outlook (Revenue, USD Billion, 2021-2033)
- West
- Southeast
- Southwest
- Northeast
- Midwest
Why should you buy this report?
- Comprehensive Market Analysis: Access detailed insights across key regions and segments.
- Competitive Landscape: Examine the market presence and strategies of leading players.
- Future Trends: Understand pivotal trends and growth drivers shaping the market's future.
- Actionable Recommendations: Leverage insights to identify new revenue streams and inform strategic decisions.
This report addresses:
- Market intelligence to facilitate effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for comprehensive market assessment
- Competition strategy and market share analysis
- Product innovation listings to maintain a competitive edge
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value (USD) in 2025 | $8.4 Billion |
| Forecasted Market Value (USD) by 2033 | $12.4 Billion |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | United States |
Companies Featured
- Church & Dwight Co., Inc.
- Reckitt Benckiser Group Plc
- Organon Group of Companies
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cooper Companies, Inc.
- Mayer Laboratories Inc
- Agile Therapeutics
- Mayne Pharma Group Limited.
- Bayer AG
- Afaxys, Inc.
- AbbVie
- Gedeon Richter
For more information about this report visit https://www.researchandmarkets.com/r/szvqh5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
